WHO puts ‘temporary pause’ on hydroxychloroquine trial for coronavirus patients

A trial of hydroxychloroquine for COVID-19 treatment has been suspended after researchers found patients receiving the drug were at higher risk of heart problems and death.

The rise of community-associated golden staph infections

There has been an increase in incidents of community-associated Staphylococcus aureus bloodstream infections (CA-SABs) in Victoria and Western Australia (WA). Pharmacists have a role...

Preparing to vaccinate children under 12 against COVID-19

On 5 December, the Therapeutic Goods Administration (TGA) provisionally approved Pfizer’s COVID-19 vaccine for children over 5 years of age.

The pharmacy role models shaping the profession’s next generation

Four of PSA’s Intern Training Program leads share the highlights of their diverse careers, and what you can expect to encounter during this challenging and exciting year.

Young pharmacy stars on the rise

Finalists for the 2022 Pharmacy Student of the Year award have been selected, with the national final scheduled to take place at PSA22.

Running for the shelter of a ‘mother’s little helper’

The popularisation of meprobamate from the 1950s onwards ushered in the dawn of the psychopharmacological era where patients began to look to doctors to...